3-indazolyl-4-pyridylisothiazoles

Details for Australian Patent Application No. 2009232263 (hide)

Owner Eli Lilly and Company

Inventors Fivush, Adam Michael; Hollinshead, Sean Patrick; Vokits, Benjamin Paul; Dehlinger, Veronique; Britton, Thomas Charles

Agent Spruson & Ferguson

Pub. Number AU-A-2009232263

PCT Pub. Number WO2009/123855

Priority 61/042,394 04.04.08 US

Filing date 18 March 2009

Wipo publication date 8 October 2009

International Classifications

C07D 417/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

A61K 31/4439 (2006.01)

A61P 25/22 (2006.01) Drugs for disorders of the nervous system

Event Publications

16 September 2010 PCT application entered the National Phase

  PCT publication WO2009/123855 Priority application(s): WO2009/123855

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009232276-Antiviral drugs for treatment of arenavirus infection

2009232242-Non-isolated charger with bi-polar inputs